CASI Pharmaceuticals Jumps 24% After Hours Despite Nasdaq Delisting
CASI shares rose over 24% in after-hours trading even as the company faces Nasdaq delisting and plans to shift trading to OTC Markets.
- Beyond The Veil Editorial
- Published
- 6 min read
- New York, United States
Event chart
- Chart time
- · 03:02 EST local · Cast for the report's publication time
- Chart location
- New York, United States (40.71°N, 74.01°W)
Tropical zodiac · Placidus houses · mean lunar nodes · Waxing Gibbous
Tightest aspects
- Moon quincunx Plutoorb 0.17°
- Saturn conjunct Neptuneorb 0.48°
- Mars square Uranusorb 0.87°
- Mercury conjunct Venusorb 2.41°
- Saturn sextile Plutoorb 3.03°
Placements
- Sun7°56′ Pis
- Moon4°38′ Can
- Mercury22°33′ Pis R
- Venus20°09′ Pis
- Mars26°48′ Aqu
- Jupiter15°20′ Can R
- Saturn1°25′ Ari
- Uranus27°40′ Tau
- Neptune0°57′ Ari
- Pluto4°27′ Aqu
- Cast for the moment the source report was published, not a verified time of the event itself.
CASI Pharmaceuticals (NASDAQ: CASI) ripped more than 24% higher in after-hours trading—up to roughly $0.28—at the exact moment the company is staring down a formal Nasdaq delisting and signaling a move to OTC Markets. That’s not the “normal” script: delisting headlines typically crush liquidity expectations, not ignite a bid.
This kind of upside glitch is where mundane astrology gets useful: when the sky says “re-price it now” even while the fundamentals scream “structural damage.”
Veil Glimpse: When a market surges on bad news, you’re watching positioning and narrative control fight for dominance in real time.
Read with an account
The Veil is free. Behind The Veil is $14.99 per month for full premium decodes, the archive, and the Veil Agent.